General

Therapeutic Goods Administration(TGA)

Australia's regulatory agency for therapeutic goods including prescription medicines, medical devices, and biologicals.

Usage Examples

TGA granted provisional approval for the COVID vaccine.
The ARTG listing enables distribution in Australia.
Abridged evaluation relied on FDA approval.

What is TGA?

The Therapeutic Goods Administration (TGA) is Australia's regulatory authority for therapeutic goods. TGA is part of the Department of Health and regulates medicines, medical devices, biologicals, and other therapeutic products.

TGA registration pathways include evaluation (full assessment), abridged evaluation (leveraging overseas approvals), and provisional approval for promising new medicines. The Australian Register of Therapeutic Goods (ARTG) lists approved products.

TGA participates in international initiatives including Access Consortium (with FDA, Health Canada, Swissmedic, and MHRA) for collaborative reviews.

Regulatory Context

This term appears most often in general workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside THERAPEUTIC GOODS ACT 1989.

FDAICHHealth Canada

When This Matters

TGA granted provisional approval for the COVID vaccine.
The ARTG listing enables distribution in Australia.
Abridged evaluation relied on FDA approval.

Common Mistakes

Relying on generic terminology without mapping to the active jurisdiction context.
Skipping cross-links between terms, tools, and active regulatory references.
Failing to maintain a single source of truth for regulatory definitions internally.

Related Regulations

THERAPEUTIC GOODS ACT 1989

Frequently Asked Questions

Provisional approval allows early access to promising new medicines where the benefit outweighs risk despite less comprehensive data than required for full registration. It requires post-market commitments.

A coalition of TGA, FDA, Health Canada, Swissmedic, and MHRA that shares information and may conduct collaborative reviews to enable faster access to new medicines.